Summary of operations and the factors that make a significant change Summary of Operations for the Year 2023 Operation Overview Annual Balance Change 2023 2022 2023 VS 2022 Million baht (MB) (MB) % Total
www.interpharma.co.th Inter Pharma Co. Ltd. 140/9 ITF Tower, 9th Floor, Silom Road, Suriyawong, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th Type of Revenue 2019 2018 Change MB
Change 9M/2018 9M/2017 Change MB MB % MB MB % Services income from debts collection and others 77.7 60.5 28.4% 201.8 177.0 14.0% Revenues from collection of purchased accounts receivables 369.3 288.9 27.8
-2022 Balance by Quarter Change Topic Q1-22 Q4-21 Q1-21 Q1-22 VS Q4-21 Q1-22 VS Q1-21 (Million Baht: MB) (MB) % (MB) % Total revenue 1,399.2 1,620.3 1,824.2 (221.1) (13.6) (425.0) (23.3) Total operating
Document Type -- Select Security Type -- Financial Statements Annual Registration Statement (Form 56-1) Annual Report (Form 56-2) Key Financial Ratio Issuer / Underlying / Securities Date From To Reset
data, particularly those from outside the company. In addition, any forward looking statements are subject to change as market conditions and actual outcomes may differ from forecasts. BAM makes no
enhanced to 28% 9M'2016 9M'2017 % change million Baht million Baht y-on-y Sales and service income 20,691 23,720 14.6% EBITDA 5,679 6,626 16.7% Net profit 2,473 2,823 14.1% Normalized net profit (NNP)* 1,966
derives in Philippines. Details are as follow: Buyer (Remained No Change) Cal-Comp Electronics (Philippines) Inc. (“CCPH”), a wholly-owned subsidiary of the Company Seller (Remained No Change) Kinpo
Type of Instruments December 2019 September 2019 December 2018 Change (%) Amount Portion Amount Portion Amount Portion September 2019 December 2018 Senior unsecured notes 99,530 66.3% 101,007 66.0
due to the following contributing factors: Operating Performance by Plant Type (IPP) Operating Results: Independent Power Producer (IPP) Operating results (unit: THB million) Q2/19 Q1/20 Q2/20 Change